These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30811662)

  • 1. Disseminated skin necroses in a patient with multiple myeloma and monoclonal cryoglobulinaemia.
    Gambichler T; Schug T; Doerler M
    J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):e166-e167. PubMed ID: 30811662
    [No Abstract]   [Full Text] [Related]  

  • 2. [A 73-year-old patient with varying, ulcerating skin necroses of the distal extremities].
    Beuckelmann DJ; Pilz G; Steinbeck G
    Internist (Berl); 1989 Nov; 30(11):764-7. PubMed ID: 2514155
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term remission of acquired von Willebrand syndrome associated with multiple myeloma using bortezomib and dexamethasone therapy.
    Katagiri S; Akahane D; Amano K; Ohyashiki K
    Haemophilia; 2016 Nov; 22(6):e557-e559. PubMed ID: 27641423
    [No Abstract]   [Full Text] [Related]  

  • 4. Dramatic resolution of disseminated pyoderma gangrenosum associated with monoclonal gammopathy after therapy with bortezomib and dexamethasone.
    Velasco-Tamariz V; Carreño-Tarragona G; Tous-Romero F; Gil-de la Cruz E; Martín-Clavero E; Rivera-Díaz R
    Int Wound J; 2017 Dec; 14(6):1382-1384. PubMed ID: 28371346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe leg ulcers in a multiple myeloma patient with cryoglobulinemic vasculitis.
    Jiménez-Encarnación E; García-Pallas MV; Vilá LM
    P R Health Sci J; 2012 Jun; 31(2):71. PubMed ID: 22783699
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report.
    Noto R; Kamiura N; Ono Y; Tabata S; Hara S; Yokoi H; Yoshimoto A; Yanagita M
    BMC Nephrol; 2017 Apr; 18(1):127. PubMed ID: 28385149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal involvement during type 1 cryoglobulinemia].
    Zaidan M; Plasse F; Rabant M; Javaugue V; Knebelmann B; Alyanakian MA; Joly D; Nochy D; Bridoux F
    Nephrol Ther; 2016 Apr; 12 Suppl 1():S71-81. PubMed ID: 26972092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lenalidomide for the treatment of cryoglobulinemia and undifferentiated spondyloarthropathy in a patient with multiple myeloma.
    Lin RJ; Curran JJ; Zimmerman TM; Song J; Niewold TB; Sweiss NJ
    J Clin Rheumatol; 2010 Mar; 16(2):90-1. PubMed ID: 20130475
    [No Abstract]   [Full Text] [Related]  

  • 9. The Addition of Low-dose Thalidomide to Bortezomib and Dexamethasone for Refractory Multiple Myeloma.
    Hashimoto S; Kuroha T; Yano T; Sato N; Furukawa T
    Intern Med; 2016; 55(20):3025-3028. PubMed ID: 27746443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful management of cryoglobulinemia-induced leukocytoclastic vasculitis with thalidomide in a patient with multiple myeloma.
    Cem Ar M; Soysal T; Hatemi G; Salihoglu A; Yazici H; Ulku B
    Ann Hematol; 2005 Sep; 84(9):609-13. PubMed ID: 15906029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic epidermal necrolysis (Lyell syndrome) as a severe and fatal manifestation of multiple myeloma with amyloidosis in a patient with rapidly progressing end-stage renal disease.
    Kępska-Dzilińska M; Kohmann A; Kuriga M; Puła B; Matuszkiewicz-Rowińska J; Małyszko J
    Pol Arch Intern Med; 2019 Nov; 129(11):819-821. PubMed ID: 31418750
    [No Abstract]   [Full Text] [Related]  

  • 12. Resolution of bilateral cystoid macular edema and subfoveal serous retinal detachments after treatment with bortezomib in a patient with "smoldering" multiple myeloma.
    Grannis CH; Dewan VN; Wang RC
    Retin Cases Brief Rep; 2014; 8(4):348-51. PubMed ID: 25372546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful treatment with a combination of lenalidomide and dexamethasone for cryoglobulinemia associated with multiple myeloma].
    Taniguchi H; Imaizumi Y; Makiyama J; Ando K; Sawayama Y; Imanishi D; Taguchi J; Tsushima H; Hata T; Miyazaki Y
    Rinsho Ketsueki; 2014 Aug; 55(8):953-7. PubMed ID: 25186485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobster claw syndrome.
    Mumoli N
    QJM; 2012 Oct; 105(10):1017. PubMed ID: 21914714
    [No Abstract]   [Full Text] [Related]  

  • 15. Late onset of bortezomib-associated cutaneous reaction following herpes zoster.
    Varettoni M; Vassallo C; Borroni G; Mangiacavalli S; Zappasodi P; Rosso R; Lazzarino M; Corso A
    Ann Hematol; 2007 Apr; 86(4):301-2. PubMed ID: 17131123
    [No Abstract]   [Full Text] [Related]  

  • 16. [A woman with a progressive skin tumor during immunotherapy].
    Sandberg Y; Sprenger R; den Bakker MA
    Ned Tijdschr Geneeskd; 2020 Mar; 164():. PubMed ID: 32391990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A cohort study comparing the efficacy and safety of bortezomib plus dexamethasone versus bortezomib, epirubicin and dexamethasone in patients with multiple myeloma].
    Hao QY; Chen H; Liu KY; Wen L; Huang XJ; Lu J
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):689-94. PubMed ID: 27586976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leg ulcers in active lepromatous leprosy associated with cryoglobulinaemia.
    Thappa DM; Karthikeyan K; Vijaikumar M; Koner BC; Jayanthi S
    Clin Exp Dermatol; 2002 Sep; 27(6):451-3. PubMed ID: 12372082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Images in clinical medicine. Gangrene and type I cryoglobulinemia in multiple myeloma.
    Cirasino L; Barbano PR
    N Engl J Med; 1999 Nov; 341(21):1582. PubMed ID: 10564688
    [No Abstract]   [Full Text] [Related]  

  • 20. Disseminated Cryptococcosis in a Patient with Multiple Myeloma Treated with Daratumumab, Lenalidomide, and Dexamethasone.
    Sato S; Kambe E; Tamai Y
    Intern Med; 2019 Mar; 58(6):843-847. PubMed ID: 30449801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.